BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36773046)

  • 1. Midbrain and pons MRI shape analysis and its clinical and CSF correlates in degenerative parkinsonisms: a pilot study.
    Painous C; Pascual-Diaz S; Muñoz-Moreno E; Sánchez V; Pariente JC; Prats-Galino A; Soto M; Fernández M; Pérez-Soriano A; Camara A; Muñoz E; Valldeoriola F; Caballol N; Pont-Sunyer C; Martin N; Basora M; Tio M; Rios J; Martí MJ; Bargalló N; Compta Y
    Eur Radiol; 2023 Jul; 33(7):4540-4551. PubMed ID: 36773046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined CSF α-SYN RT-QuIC, CSF NFL and midbrain-pons planimetry in degenerative parkinsonisms: From bedside to bench, and back again.
    Compta Y; Painous C; Soto M; Pulido-Salgado M; Fernández M; Camara A; Sánchez V; Bargalló N; Caballol N; Pont-Sunyer C; Buongiorno M; Martin N; Basora M; Tio M; Giraldo DM; Pérez-Soriano A; Zaro I; Muñoz E; Martí MJ; Valldeoriola F
    Parkinsonism Relat Disord; 2022 Jun; 99():33-41. PubMed ID: 35594661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.
    Eraslan C; Acarer A; Guneyli S; Akyuz E; Aydin E; Colakoglu Z; Kitis O; Calli MC
    Neurol Res; 2019 Feb; 41(2):110-117. PubMed ID: 30373485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP.
    Mangesius S; Hussl A; Krismer F; Mahlknecht P; Reiter E; Tagwercher S; Djamshidian A; Schocke M; Esterhammer R; Wenning G; Müller C; Scherfler C; Gizewski ER; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2018 Jan; 46():47-55. PubMed ID: 29126761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers.
    Mangesius S; Mariotto S; Ferrari S; Pereverzyev S; Lerchner H; Haider L; Gizewski ER; Wenning G; Seppi K; Reindl M; Poewe W
    Parkinsonism Relat Disord; 2020 Aug; 77():57-63. PubMed ID: 32622301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New and reliable MRI diagnosis for progressive supranuclear palsy.
    Oba H; Yagishita A; Terada H; Barkovich AJ; Kutomi K; Yamauchi T; Furui S; Shimizu T; Uchigata M; Matsumura K; Sonoo M; Sakai M; Takada K; Harasawa A; Takeshita K; Kohtake H; Tanaka H; Suzuki S
    Neurology; 2005 Jun; 64(12):2050-5. PubMed ID: 15985570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
    Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
    Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
    Paviour DC; Thornton JS; Lees AJ; Jäger HR
    Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated brainstem volumetry can aid in the diagnostics of parkinsonian disorders.
    Sjöström H; Granberg T; Hashim F; Westman E; Svenningsson P
    Parkinsonism Relat Disord; 2020 Oct; 79():18-25. PubMed ID: 32858488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
    Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
    Mov Disord; 2006 Jul; 21(7):989-96. PubMed ID: 16602104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "One line": A method for differential diagnosis of parkinsonian syndromes.
    Sako W; Abe T; Haji S; Murakami N; Osaki Y; Izumi Y; Harada M; Kaji R
    Acta Neurol Scand; 2019 Sep; 140(3):229-235. PubMed ID: 31225648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
    Kurata T; Kametaka S; Ohta Y; Morimoto N; Deguchi S; Deguchi K; Ikeda Y; Takao Y; Ohta T; Manabe Y; Sato S; Abe K
    Intern Med; 2011; 50(22):2775-81. PubMed ID: 22082889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid NFL in the differential diagnosis of parkinsonian disorders: A meta-analysis.
    Ge F; Ding J; Liu Y; Lin H; Chang T
    Neurosci Lett; 2018 Oct; 685():35-41. PubMed ID: 30036569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy.
    Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
    Brain; 2006 Apr; 129(Pt 4):1040-9. PubMed ID: 16455792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manual MRI morphometry in Parkinsonian syndromes.
    Möller L; Kassubek J; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Pinkhardt EH; Respondek G; Stamelou M; Möller F; Schnitzler A; Oertel WH; Knake S; Huppertz HJ; Höglinger GU
    Mov Disord; 2017 May; 32(5):778-782. PubMed ID: 28150443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis.
    Sako W; Murakami N; Izumi Y; Kaji R
    J Neurol Sci; 2015 May; 352(1-2):84-7. PubMed ID: 25868897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple linear brainstem MRI measurements in the differential diagnosis of progressive supranuclear palsy from the parkinsonian variant of multiple system atrophy.
    Constantinides VC; Paraskevas GP; Stamboulis E; Kapaki E
    Neurol Sci; 2018 Feb; 39(2):359-364. PubMed ID: 29196955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
    Yekhlef F; Ballan G; Macia F; Delmer O; Sourgen C; Tison F
    J Neural Transm (Vienna); 2003 Feb; 110(2):151-69. PubMed ID: 12589575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
    Holmberg B; Rosengren L; Karlsson JE; Johnels B
    Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy.
    Carlos AF; Sekiya H; Koga S; Pham NTT; Ali F; Botha H; Clark HM; Coon EA; Lowe V; Ahlskog JE; Trejo-Lopez JA; Dickson DW; Whitwell JL; Josephs KA
    Parkinsonism Relat Disord; 2022 Aug; 101():9-14. PubMed ID: 35752126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.